Bulletin physiology and pathology of respiration,
Journal Year:
2023,
Volume and Issue:
89, P. 79 - 87
Published: Sept. 28, 2023
Introduction.
Currently,
there
is
a
separate
phenotype
“bronchial
asthma
–
obesity”,
manifested
by
more
severe
course
of
the
disease,
low
rates
achieving
control,
resistance
to
basic
therapy.
Asthma,
like
obesity,
recognized
as
classic
example
multifactorial
diseases,
which
are
based
on
rather
complex
gene
network.
The
active
search
for
genetic
markers
characterizing
individual
characteristics
human
metabolism
continues.
Of
particular
interest
genes
involved
in
regulation
fat
and
carbohydrate
metabolism.
Aim.
Analysis
associations
polymorphic
loci
Ala54Thr
(G163A)
FABP2
with
bronchial
varying
severity
control
children.
Materials
methods.
161
children
remission
were
examined
continuous
sampling
method,
59
patients
obesity
1-3
degrees
without
concomitant
endocrine
pathology.
examination
included
general
clinical,
functional,
instrumental
level
was
determined
according
GINA
criteria
(2018).
biochemical
study
carried
out
an
automatic
analyzer
SAPPHIRE
400
(Japan).
polymorphisms
real-time
polymerase
chain
reaction
using
sets
“Metabolism”
(Research
Production
Company
“Litekh”,
Moscow)
CFX-96
Biorat
device
(USA).
Results.
We
have
not
identified
presence
obesity.
It
that
asthma,
frequency
carrying
homozygous
genotype
Thr/Thr
minor
allele
Thr
increased
1.5
times
compared
group
(OR
9.043;
95%CI
[2,093–39,073],
p=0.0011
OR
2.946;
[1,698‒5,111],
p=0.001,
respectively),
carriage
rare
A
risk
uncontrolled
2.42;
[1.23‒4.79],
p=0.03
1.75;
[1,119‒2,736],
p=0.01),
Ala/Ala
frequent
Ala
detected
often
associated
2.176;
[1.001‒4.727],
p=0.0008
2.378;
[1.495‒3.780],
p=0.0002,
respectively).
Conclusion.
Although
we
it
has
been
shown
Ala54Thr+Thr54Тhr
genotypes
significantly
higher
glucose
levels
(4.9±0.06
mmol/L
carriers
Ala54Ala
4.0±0.06
mmol/L,
p<0.001),
cholesterol
(4.8±0.4
3.93±0.1
p<0.05)
density
lipoproteins
(2.55±0.09
2.26±0.1
p<0.05).
There
obvious
need
further
investigation
effect
polymorphism
indicators
lipid
metabolism,
depending
nature
diets.
These
issues
require
part
probable
cause-and-effect
relationships
creation
personalized
programs
variants.
Russian Journal of Gastroenterology Hepatology Coloproctology,
Journal Year:
2024,
Volume and Issue:
34(6), P. 28 - 41
Published: Dec. 30, 2024
Aim:
to
study
the
levels
of
fatty
acids
in
membranes
erythrocytes
and
blood
serum
patients
with
inflammatory
bowel
diseases
(IBD)
examined
over
time,
as
possible
predictors
exacerbation
disease.
Materials
methods.
Over
a
period
6–12
months,
24
(mean
age
—
38.2
±
4.4
years)
IBD
moderate
mild
severity
disease
were
examined,
which
10
had
ulcerative
colitis,
Crohn’s
disease,
4
unclassified
colitis:
first
examination
was
acute
stage,
second
remission
stage.
In
48
additionally
(25
15
8
colitis),
course
monitored
next
12
months.
The
comparison
group
included
53
people
comparable
main
groups
age.
composition
(FAs)
carried
out
using
gas
chromatograph
mass
spectrometry
system
based
on
three
quadrupoles
Agilent
7000B
(Agilent
Technologies
Inc.,
USA).
Results.
have
higher
total
content
saturated
(SFAs)
erythrocyte
compared
control
(
p
=
0.006),
and,
contrary,
lower
unsaturated
(UFAs)
0.005),
mainly
due
polyunsaturated
FAs
(PUFAs)
0.026),
namely
omega-6
PUFAs
0.011).Remission
is
associated
an
increase
level
number
SFAs
margaric
C17:0
0.024),
arachidic
acid
(C20:0)
0.0001
0.019,
respectively),
decrease
monounsaturated
0.022),
concentration
both
omega-3
0.0008)
0.033)
healthy
individuals.The
stage
time
stearic
FA
C18:0
SFA/UFA
0.034)
SFA/PUFA
0.039)
ratios
membranes,
C20:0
0.008),
UFAs
eicosapentaenoic
C20:5n-3
0.0023),
eicosadienoic
C20:2n-6
0.0027),
hexadecadienoic
C16:2n-6
docosatetraenoic
C22:4n-6
0.008)
alpha-linolenic
C18:3n-3
0.039).A
combined
“panel”
acids,
including
C20:2n-6,
serum,
provided
AUC
0.683
(95
%
CI:
0.500–0.844),
sensitivity
91.4
%,
specificity
68.3
%.Levels
C20:5n-3,
C18:0,
C16:2n-6,
C22:4n-6,
used
biomarkers
development
who
remission,
predicted
after
2–4
months
case
maximally
changed
FAs,
6–8
moderately
maintaining
for
minimally
levels.
Conclusion.
Fatty
should
be
considered
promising
markers
further
studies
related
diagnosis
prediction
IBD.
ChemistrySelect,
Journal Year:
2024,
Volume and Issue:
9(32)
Published: Aug. 23, 2024
Abstract
Two
aggregation
induced
emission
molecules
(
TPE‐MZ
and
QM‐Py‐TPE
)
have
been
synthesized
characterized.
Similar
to
conventional
AIE
based
molecules,
both
displayed
good
sensitivity
towards
water
fraction
viscosity
of
dispersing
medium.
The
fluorescent
intensity
gradually
reduced
with
increasing
concentration
oleic
acid
elaidic
within
the
range
0.2–5
mM.
inflection
points
maximum
for
were
observed
at
1.40
0.80
mM,
respectively.
corresponding
1.80
2.00
mM
acid,
Sensor
combination
:
=2
1)
emitted
pink
yellow
fluorescence
in
acid.
Fluorescent
ratio
I
646
/I
508
sensor
acceptable
linear
relationship
(R
2
=0.9826)
(within
4
mM).
Thus,
was
capable
naked‐eye
discriminating
quantitively
sensing.
Bulletin physiology and pathology of respiration,
Journal Year:
2023,
Volume and Issue:
89, P. 79 - 87
Published: Sept. 28, 2023
Introduction.
Currently,
there
is
a
separate
phenotype
“bronchial
asthma
–
obesity”,
manifested
by
more
severe
course
of
the
disease,
low
rates
achieving
control,
resistance
to
basic
therapy.
Asthma,
like
obesity,
recognized
as
classic
example
multifactorial
diseases,
which
are
based
on
rather
complex
gene
network.
The
active
search
for
genetic
markers
characterizing
individual
characteristics
human
metabolism
continues.
Of
particular
interest
genes
involved
in
regulation
fat
and
carbohydrate
metabolism.
Aim.
Analysis
associations
polymorphic
loci
Ala54Thr
(G163A)
FABP2
with
bronchial
varying
severity
control
children.
Materials
methods.
161
children
remission
were
examined
continuous
sampling
method,
59
patients
obesity
1-3
degrees
without
concomitant
endocrine
pathology.
examination
included
general
clinical,
functional,
instrumental
level
was
determined
according
GINA
criteria
(2018).
biochemical
study
carried
out
an
automatic
analyzer
SAPPHIRE
400
(Japan).
polymorphisms
real-time
polymerase
chain
reaction
using
sets
“Metabolism”
(Research
Production
Company
“Litekh”,
Moscow)
CFX-96
Biorat
device
(USA).
Results.
We
have
not
identified
presence
obesity.
It
that
asthma,
frequency
carrying
homozygous
genotype
Thr/Thr
minor
allele
Thr
increased
1.5
times
compared
group
(OR
9.043;
95%CI
[2,093–39,073],
p=0.0011
OR
2.946;
[1,698‒5,111],
p=0.001,
respectively),
carriage
rare
A
risk
uncontrolled
2.42;
[1.23‒4.79],
p=0.03
1.75;
[1,119‒2,736],
p=0.01),
Ala/Ala
frequent
Ala
detected
often
associated
2.176;
[1.001‒4.727],
p=0.0008
2.378;
[1.495‒3.780],
p=0.0002,
respectively).
Conclusion.
Although
we
it
has
been
shown
Ala54Thr+Thr54Тhr
genotypes
significantly
higher
glucose
levels
(4.9±0.06
mmol/L
carriers
Ala54Ala
4.0±0.06
mmol/L,
p<0.001),
cholesterol
(4.8±0.4
3.93±0.1
p<0.05)
density
lipoproteins
(2.55±0.09
2.26±0.1
p<0.05).
There
obvious
need
further
investigation
effect
polymorphism
indicators
lipid
metabolism,
depending
nature
diets.
These
issues
require
part
probable
cause-and-effect
relationships
creation
personalized
programs
variants.